Literature DB >> 27076941

Robot-assisted coronary artery bypass grafting improves short-term outcomes compared with minimally invasive direct coronary artery bypass grafting.

Wenhui Gong1, Junfeng Cai1, Zhe Wang1, Anqing Chen1, Xiaofeng Ye1, Haiqing Li1, Qiang Zhao1.   

Abstract

BACKGROUND: Robot-assisted coronary artery bypass grafts (RACAB) utilizing the da Vinci surgical system are increasingly used and allow the surgeon to conveniently harvest internal mammary arteries (IMAs). The aim of this study was to compare the outcomes of off-pump RACAB and minimally invasive direct coronary artery bypass grafting (MIDCAB) in the short and medium term.
METHODS: We performed a retrospective review of 132 patients with single- or multiple-vessel coronary artery disease who underwent minimally invasive off-pump CABG (OPCAB) between May 2009 and May 2014. The patients were divided into two groups based on the surgical approach, MIDCAB and RACAB group. The anastomosis of the left internal mammary artery (LIMA) to the left anterior descending artery (LAD) was performed as regular OPCAB through the incision on the beating heart using regular stabilization devices (Genzyme Corporation). The preoperative, intraoperative, postoperative, and follow-up data, including major adverse cardiac and cerebrovascular events (MACCE), were compared.
RESULTS: The preoperative data were similar. RACAB significantly shorten the intensive care unit (ICU) stay and postoperative compared with the MIDCAB group (P<0.05). There were 12 (19.7%) patients treated with a two-stage hybrid procedure in the MIDCAB group and 34 (47.9%) patients in the RACAB group (P=0.001). Thirty-day mortality was 1.6% in the MIDCAB group. There were 9 (14.7%) MIDCAB patients and 2 (2.8%) RACAB patients (P=0.013) that developed new arrhythmia. The two groups showed comparable mid-term survival (P=0.246), but the MACCEs were significantly different (P=0.038).
CONCLUSIONS: RACAB may be a valuable alternative for patients requiring single or simple multi-vessel coronary artery bypass grafting (CABG). Although the mid-term mortality outcomes are similar, RACAB improves short-term outcomes and mid-term MACCE-free survival compared with MIDCAB.

Entities:  

Keywords:  Minimally invasive direct coronary artery bypass grafting (MIDCAB); coronary surgery; robotically assisted coronary artery bypass grafting (robotically assisted CABG); survival

Year:  2016        PMID: 27076941      PMCID: PMC4805807          DOI: 10.21037/jtd.2016.02.67

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  24 in total

1.  Minimally invasive coronary artery bypass grafting: an experimental perspective.

Authors:  C Borst; P F Gründeman
Journal:  Circulation       Date:  1999-03-23       Impact factor: 29.690

2.  Con: beating-heart surgery for coronary revascularization: is it the most important development since the introduction of the heart-lung machine?

Authors:  D A Cooley
Journal:  Ann Thorac Surg       Date:  2000-11       Impact factor: 4.330

3.  Xyphoid MIDCAB: report of the technique and experience with a less invasive MIDCAB procedure.

Authors:  M K Dullum; J Block; A Qazi; F Shawl; F Benetti
Journal:  Heart Surg Forum       Date:  1999       Impact factor: 0.676

4.  Direct-vision coronary endarterectomy for angina pectoris.

Authors:  W P LONGMIRE; J A CANNON; A A KATTUS
Journal:  N Engl J Med       Date:  1958-11-20       Impact factor: 91.245

5.  Minimally invasive coronary artery bypass grafting via a small thoracotomy versus off-pump: a case-matched study.

Authors:  Harry Lapierre; Vincent Chan; Benjamin Sohmer; Thierry G Mesana; Marc Ruel
Journal:  Eur J Cardiothorac Surg       Date:  2011-03-09       Impact factor: 4.191

6.  Robot-assisted coronary artery bypass.

Authors:  Hirofumi Takemura
Journal:  Circ J       Date:  2014-01-07       Impact factor: 2.993

7.  Anatomy-based eligibility measure for robotic-assisted bypass surgery.

Authors:  Abelardo Escoto; Ana Luisa Trejos; Rajni V Patel; Aashish Goela; Bob Kiaii
Journal:  Innovations (Phila)       Date:  2014 Sep-Oct

Review 8.  Off-pump complete revascularization through a left lateral thoracotomy (ThoraCAB): the first 200 cases.

Authors:  Sudhir P Srivastava; Kirit N Patel; Rajaratnam Skantharaja; Reyna Barrera; Diana Nanayakkara; Vishwa Srivastava
Journal:  Ann Thorac Surg       Date:  2003-07       Impact factor: 4.330

9.  Hypoxemia during one-lung ventilation for robot-assisted coronary artery bypass graft surgery.

Authors:  Tsun-Jui Liu; Meng-Shen Shih; Wen-Lieng Lee; Kuo-Yang Wang; Chia-Ning Liu; Chih-Jen Hung; Hui-Chin Lai
Journal:  Ann Thorac Surg       Date:  2013-05-31       Impact factor: 4.330

10.  Mid-Term Outcomes of Minimally Invasive Direct Coronary Artery Bypass Grafting.

Authors:  Diana Reser; Mathias van Hemelrijck; Jovana Pavicevic; Herman Tolboom; Tomas Holubec; Volkmar Falk; Stephan Jacobs
Journal:  Thorac Cardiovasc Surg       Date:  2014-09-10       Impact factor: 1.827

View more
  10 in total

1.  Establishment of a minimally invasive cardiac surgery programme in Singapore.

Authors:  Theo Kofidis; Guo Hao Chang; Chuen Neng Lee
Journal:  Singapore Med J       Date:  2017-07-06       Impact factor: 1.858

2.  The surgical outcomes of robot-assisted laparoscopic pancreaticoduodenectomy versus laparoscopic pancreaticoduodenectomy for periampullary neoplasms: a comparative study of a single center.

Authors:  Rong Liu; Tao Zhang; Zhi-Ming Zhao; Xiang-Long Tan; Guo-Dong Zhao; Xuan Zhang; Yong Xu
Journal:  Surg Endosc       Date:  2016-09-08       Impact factor: 4.584

3.  Robot-assisted coronary artery bypass surgery: a systematic review and meta-analysis of comparative studies.

Authors:  Fadi Hammal; Fernanda Nagase; Devidas Menon; Imtiaz Ali; Jeevan Nagendran; Tania Stafinski
Journal:  Can J Surg       Date:  2020 Nov-Dec       Impact factor: 2.089

Review 4.  Minimally invasive surgery or stenting for left anterior descending artery disease - meta-analysis.

Authors:  Monica Gianoli; Anne R de Jong; Kirolos A Jacob; Hanae F Namba; Niels P van der Kaaij; Pim van der Harst; Willem J L Suyker
Journal:  Int J Cardiol Heart Vasc       Date:  2022-05-10

Review 5.  Minimally invasive and robotic coronary artery bypass grafting-a 25-year review.

Authors:  Johannes Bonatti; Stephanie Wallner; Ingo Crailsheim; Martin Grabenwöger; Bernhard Winkler
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

6.  Early home discharge after robot-assisted coronary artery bypass grafting.

Authors:  Alexander Spanjersberg; Leendert Hoek; Jan Paul Ottervanger; Thi-Yen Nguyen; Emel Kaplan; Roland Laurens; Sandeep Singh
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-06-15

7.  Robot-assisted vs. conventional MIDCAB: A propensity-matched analysis.

Authors:  Jan Gofus; Stepan Cerny; Youssef Shahin; Zdenek Sorm; Martin Vobornik; Petr Smolak; Ananya Sethi; Samuel Marcinov; Mikita Karalko; James Chek; Jan Harrer; Jan Vojacek; Marek Pojar
Journal:  Front Cardiovasc Med       Date:  2022-08-30

8.  Minimally invasive left internal mammary artery harvesting techniques during the learning curve are safe and achieve similar results as conventional LIMA harvesting techniques.

Authors:  Matiullah Masroor; Chunyang Chen; Kang Zhou; Xianming Fu; Umar Zeb Khan; Yuan Zhao
Journal:  J Cardiothorac Surg       Date:  2022-08-24       Impact factor: 1.522

9.  Eleven-year outcomes of U-clips in totally robotic coronary artery bypass grafting versus standard hand-sewn running suture in robotic-assisted coronary artery bypass grafting.

Authors:  Nan Cheng; Huajun Zhang; Ming Yang; Guopeng Liu; Yi Guo; Wenbin Kang; Changqing Gao; Rong Wang
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-06-28

10.  Assessment of Physical Activity by Wearable Technology During Rehabilitation After Cardiac Surgery: Explorative Prospective Monocentric Observational Cohort Study.

Authors:  Isabeau Thijs; Libera Fresiello; Wouter Oosterlinck; Peter Sinnaeve; Filip Rega
Journal:  JMIR Mhealth Uhealth       Date:  2019-01-31       Impact factor: 4.773

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.